ArticleCureus2024
Distributive and Refractory Shock in Myxoedema Coma.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myxoedema coma is a rare medical emergency, presenting even less commonly without sepsis and with the diagnosis of distributive shock. Reports of catecholamine-refractory shock are scarce. This report describes the case of a 54-year-old male, who presented to the emergency department with altered mental status. He was found to be hypothermic, hypotensive, and bradycardic, with poor peripheral perfusion and oedema of the face and hands. On initial evaluation, the patient was found to have acute renal failure, hyponatraemia, hyperkalaemia, and findings suggestive of metabolic acidosis. Clinical examination confirmed a suspected diagnosis of distributive shock with multiorgan dysfunction, refractory to volume, and vasopressor support. The patient was admitted to the intensive care unit for treatment and organ support. Further diagnostic studies revealed an elevated thyroid-stimulating hormone level and decreased T3 and T4, favouring the diagnosis of myxoedema coma. Hydrocortisone and levothyroxine were initiated intravenously for the treatment of suspected myxoedema coma, resulting in rapid clinical improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.